PACE GARY W

CIK 00011847784 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001184778

Recent Transactions

50 trades

Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2025-07-30$2.45/sh+275,000→ 1,330,676 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2025-07-30$2.45/sh+15,000→ 1,345,676 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2025-06-26+40,565→ 187,539 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2024-12-11$2.60/sh+350,115→ 1,047,876 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2024-12-11$2.60/sh+11,500→ 1,059,376 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2024-06-27+29,700→ 146,974 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-03-08$30.60/sh−90,000→ 22,127 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-03-07$30.81/sh−28,257→ 112,127 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2024-03-06$29.67/sh−1,066→ 140,384 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2023-12-19$1.37/sh+30,000→ 697,761 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2023-11-10$0.98/sh+22,950→ 667,761 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2023-06-15+27,700→ 117,274 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-06-14+1,775→ 141,450 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2023-06-14+12,925→ 12,925 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-05-11$41.78/sh−5,015→ 139,675 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2023-05-11−7,000→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2023-05-11$29.90/sh+7,000→ 144,690 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2022-09-15$1.71/sh+150,000→ 644,811 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-06-08+1,160→ 137,690 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-06-08+8,225→ 8,225 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2022-03-09+26,800→ 89,574 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-03$10.81/sh+7,000→ 136,530 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-03-03−7,000→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-03-01−1,166→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-03-01−193→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-01$11.02/sh+193→ 129,723 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-01$67.75/sh−1,359→ 129,530 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-03-01$11.02/sh+1,166→ 130,889 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-02-28−18,834→ 1,166 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2022-02-28−9,807→ 193 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-28$11.02/sh+18,834→ 158,171 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-28$11.02/sh+9,807→ 139,337 total
Sale
Pacira BioSciences, Inc.$PCRX
Common Stock
2022-02-28$66.83/sh−28,641→ 129,530 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2021-09-21$6.75/sh+30,000→ 494,811 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2021-06-10+22,000→ 62,774 total
Award
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-06-09+1,066→ 129,530 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2021-06-09+7,626→ 7,626 total
Gift
Pacira BioSciences, Inc.$PCRX
Common Stock
2021-05-13−1,485→ 128,464 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2021-03-23$10.31/sh+2,500→ 464,811 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2021-03-23$10.21/sh+2,500→ 462,311 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2021-03-23$10.20/sh+5,000→ 459,811 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2021-03-18$10.58/sh+1,000→ 452,811 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2021-03-18$10.54/sh+2,000→ 454,811 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2021-03-04$9.27/sh+1,500→ 451,811 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2020-09-25−70,000→ 0 total
Exercise/Conversion
Pacira BioSciences, Inc.$PCRX
Common Stock
2020-09-25$16.67/sh+70,000→ 129,949 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2020-09-16$5.69/sh+1,700→ 449,461 total
Purchase
Cardiff Oncology, Inc.$CRDF
Common Stock
2020-09-16$5.71/sh+850→ 450,311 total
Award
Cardiff Oncology, Inc.$CRDF
Stock Options
2020-06-17+28,858→ 40,774 total
Award
Pacira BioSciences, Inc.$PCRX
Stock Option (Right to Buy)
2020-06-09+8,027→ 8,027 total

Companies

Recent Filings

Address

RESMED INC. 9001 SPECTRUM CENTER BOULEVARD

SAN DIEGO, CA, 92123

View on SEC.gov